Comparison

Cerdulatinib hydrochloride European Partner

Item no. TMO-T6104-200mg
Manufacturer TargetMol
CASRN 1369761-01-2
Amount 200 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Smiles Cl.CCS(=O)(=O)N1CCN(CC1)c1ccc(Nc2ncc(C(N)=O)c(NC3CC3)n2)cc1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias PRT2070 hydrochloride,PRT062070 hydrochloride
Shipping Condition Cool pack
Available
Manufacturer - Targets
MLK|||c-Fms|||Syk|||JAK|||Hippo pathway|||Tyrosine Kinases
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
482
Description
Cerdulatinib hydrochloride (PRT2070 hydrochloride) is an oral active, multi-targeted tyrosine kinase inhibitor with IC50 of 12 nM/6 nM/8 nM/0.5 nM and 32 nM for JAK1/JAK2/JAK3/TYK2 and Syk, respectively. Also inhibits 19 other tested kinases with IC50 less than 200 nM.
Pathways
Angiogenesis|||Stem Cells|||Chromatin/Epigenetic|||JAK/STAT signaling|||Tyrosine Kinase/Adaptors|||MAPK
Receptor
c-Fms; MST1; ARK5; MLK1; Tyk2

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close